Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ernest C. Borden, MD
The Cleveland Clinic
- George D. Demetri, MD
Dana-Farber Cancer Institute
- Karen H. Albritton, MD
Dana-Farber Cancer Institute
- Margaret von Mehren, MD
Fox Chase Cancer Center
- Rashmi Chugh, MD
University of Michigan Rogel Cancer Center
- Vivien H.C. Bramwell, MB, BS, PhD, FRCP
Tom Baker Cancer Centre - Calgary
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2005
- Primary completion
- —
- Completion
- 31 Aug 2007
- Last update posted
- 24 Jun 2013
- Registered enrollment
- 40
- Registry id
- NCT00104949
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.